Search - tctmd.com

Displaying 321 - 340 of 421

Sort: Relevancy | Date

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How I Optimize Stent Implantation

Presenter: Jeffrey W. Moses

March 11, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Use Imaging to Optimize and Understand BRS

Presenter: Alexandre Abizaid

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

Presentation JIM 2016

Imaging modalities to guide bio-absorbable scaffolds

Presenter: Corrado Tamburino

February 11, 2016

Presentation JIM 2016

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Presenter: Azeem Latib

February 10, 2016

Presentation JIM 2016

Intravascular Imaging during BRSa pragmatic approach

Presenter: Nicolas M. Van Mieghem

February 10, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

Presentation JIM 2016

Bioresorbable Vascular Scaffolds for Chronic Total Occlusions: Clinical and Multi-imaging follow-up Outcomes

Presenter: Antonio Serra

February 10, 2016

News Daily News

OCT Reveals Potential Causes of Very Late Stent Thrombosis

Caitlin E. Cox

January 19, 2016

News Daily News

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Todd Neale

December 30, 2015

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

News Industry News

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

Advertisement

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

How I Optimize Stent Implantation

Use Imaging to Optimize and Understand BRS

Role of OCT in Evaluation and treatment of In Stent Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

REVA Achieves Target Patient Enrollment in FANTOM II Trial

Imaging modalities to guide bio-absorbable scaffolds

Novel Imaging and Physiologic Lesion Assessment Devices to Guide BRS procedures

Intravascular Imaging during BRSa pragmatic approach

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Bioresorbable Vascular Scaffolds for Chronic Total Occlusions: Clinical and Multi-imaging follow-up Outcomes

OCT Reveals Potential Causes of Very Late Stent Thrombosis

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content